Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H, Karaman M, Unal HU, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Yilmaz MI.
Kanbay M, et al. Among authors: kurt yg.
J Clin Endocrinol Metab. 2014 Oct;99(10):E1854-61. doi: 10.1210/jc.2014-2042. Epub 2014 Jul 24.
J Clin Endocrinol Metab. 2014.
PMID: 25057883